TERAPIA CELULAR Y MEDICINA REGENERATIVA
KU Leuven
Lovaina, BélgicaPublicaciones en colaboración con investigadores/as de KU Leuven (2)
2021
-
Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes
American Journal of Hematology
2018
-
Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation
Biology of Blood and Marrow Transplantation, Vol. 24, Núm. 11, pp. 2365-2370